Modulation of the c-Jun N-terminal kinase activity in the embryonic heart in response to anoxia-reoxygenation: involvement of the Ca2+ and mitoKATP channels. by Sarre, A. et al.
Modulation of the c-Jun N-terminal kinase activity
in the embryonic heart in response to anoxia-reoxygenation:
involvement of the Ca2+ and mitoKATP channels
Alexandre Sarre Æ Ste´phany Gardier Æ
Fabienne Maurer Æ Christophe Bonny Æ
Eric Raddatz
Received: 24 December 2007 / Accepted: 28 March 2008
 Springer Science+Business Media, LLC. 2008
Abstract Whether the response of the fetal heart to
ischemia-reperfusion is associated with activation of the
c-Jun N-terminal kinase (JNK) pathway is not known. In
contrast, involvement of the sarcolemmal L-type Ca2+
channel (LCC) and the mitochondrial KATP (mitoKATP)
channel has been established. This work aimed at investi-
gating the profile of JNK activity during anoxia-
reoxygenation and its modulation by LCC and mitoKATP
channel. Hearts isolated from 4-day-old chick embryos
were submitted to anoxia (30 min) and reoxygenation
(60 min). Using the kinase assay method, the profile of
JNK activity in the ventricle was determined every 10 min
throughout anoxia-reoxygenation. Effects on JNK activity
of the LCC blocker verapamil (10 nM), the mitoKATP
channel opener diazoxide (50 lM) and the blocker 5-hy-
droxydecanoate (5-HD, 500 lM), the mitochondrial Ca2+
uniporter (MCU) inhibitor Ru360 (10 lM), and the anti-
oxidant N-(2-mercaptopropionyl) glycine (MPG, 1 mM)
were determined. In untreated hearts, JNK activity was
increased by 40% during anoxia and peaked fivefold rela-
tive to basal level after 30–40 min reoxygenation. This
peak value was reduced by half by diazoxide and was
tripled by 5-HD. Furthermore, the 5-HD-mediated stimu-
lation of JNK activity during reoxygenation was abolished
by diazoxide, verapamil or Ru360. MPG had no effect on
JNK activity, whatever the conditions. None of the tested
pharmacological agents altered JNK activity under basal
normoxic conditions. Thus, in the embryonic heart, JNK
activity exhibits a characteristic pattern during anoxia and
reoxygenation and the respective open-state of LCC, MCU
and mitoKATP channel can be a major determinant of JNK
activity in a ROS-independent manner.
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Introduction
The signaling pathways involved in the response of the
fetal heart to inadequate oxygenation, resulting from
transient maternal hypoxemia, reduction in uterine or
umbilical blood flow, remain to be explored. We have
previously characterized in detail the electrical and con-
tractile disturbances induced by anoxia and reoxygenation
in the embryonic heart model [1, 2] and found that a
moderate inhibition of the sarcolemmal L-type calcium
channel (LCC) [3] or activation of the mitochondrial
ATP-sensitive potassium (mitoKATP) channel can improve
postanoxic recovery [4]. Opening of the mitoKATP chan-
nel is also involved in ischemic preconditioning of
isolated embryonic ventricular myocytes [5] and adult
heart [6].
Several studies have underlined the key role played by
the mitogen-activated protein kinases (MAPKs) pathways
[7] in myocardial ischemia and reperfusion, particularly the
stress-activated c-Jun N-terminal kinase (JNK) [8, 9]. In
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the ventricle of the anoxic-reoxygenated embryonic chick
heart, activity of the extracellular signal-regulated kinase
(ERK) is not significantly altered and the profile of the p38
MAPK phosphorylation is not affected by opening of the
mitoKATP channel [10]. However, information regarding
the JNK signaling pathway in the hypoxic fetal heart is
lacking and a better understanding is especially required in
the context of recent advances in developmental cardiology
[11], fetal cardiac surgery [12] and research dealing with
intrauterine programming [13]. Furthermore, as Ca2+ is one
of the second messengers capable of modulating JNK
activity [14], the cytosolic and mitochondrial Ca2+ over-
load induced by anoxia-reoxygenation in embryonic
cardiomyocytes [15] could interfere with the JNK signaling
pathway.
The aim of this work was to establish the profile of JNK
activity in the ventricle of the embryonic heart during
anoxia and reoxygenation and to investigate the possible
link between JNK activity and the state of activation of the
Ca2+ and mitoKATP channels. The results suggest that LCC
and mitochondrial Ca2+ and KATP channels are involved in
the modulation of JNK activity in the embryonic ventricle
submitted to anoxia-reoxygenation.
Materials and methods
Reagents
Dimethylsulfoxide (DMSO), mitoKATP channel opener
diazoxide and blocker 5-hydroxydecanoate (5-HD), radical
scavenger N-(2-mercaptopropionyl)glycine (MPG), were
purchased from Sigma (Sigma–Aldrich, Buchs, Switzer-
land). L-Type Ca2+ channel inhibitor verapamil (Isoptin)
was from Abbott and mitochondrial Ca2+ uniporter (MCU)
inhibitor Ru360 was purchased from Calbiochem (JURO
Supply, Lucerne, Switzerland).
[c-33P]ATP was from Amersham Biosciences and
inhibitors of proteases from Roche Biosciences.
Preparation and in vitro mounting of the heart
Fertilized eggs from Lohman Brown hens were incubated
during 96 h at 38C and 95% relative humidity to obtain
stage 24 HH embryo (according to Hamburger and Ham-
ilton [16]). Spontaneously beating hearts were carefully
excised and placed in the culture compartment of an air-
tight stainless steel chamber. The chamber was equipped
with two windows for observation and maintained under
controlled conditions on the thermostabilized stage
(37.5C) of an inverted microscope (IMT2 Olympus,
Tokyo, Japan) as previously detailed [4]. Briefly, the cul-
ture compartment (300 ll) was separated from the gas
compartment by a 15 lm transparent and gas-permeable
silicone membrane (RTV 141, Rhoˆne-Poulenc, Lyon,
France). Thus, pO2 at the tissue level could be strictly
controlled and rapidly modified (within less than 5 s) by
flushing high-grade gas of selected composition through
the gas compartment. At this developmental stage, the
heart lacks vascularization and the myocardial oxygen
requirement is met exclusively by diffusion.
The standard HCO3/CO2 buffered medium was com-
posed of (in mmol/l): 99.25 NaCl; 0.3 NaH2PO4; 10
NaHCO3; 4 KCl; 0.79 MgCl2; 0.75 CaCl2; 8 D+glucose.
This culture medium was equilibrated in the chamber with
2.31% CO2 in air (normoxia and reoxygenation) or in N2
(anoxia) yielding a pH of 7.4. All reagents were diluted in
this medium containing 0.5% DMSO (vehicle).
Anoxia-reoxygenation protocol
After 45 min of in vitro stabilization under normoxia at
37.5C (stab), the hearts were submitted to strict anoxia
during 30 min and then reoxygenated during 60 min. The
pharmacological agents were present throughout anoxia-
reoxygenation. The hearts were collected every 10 min
and the ventricle was carefully dissected on ice and stored
at -80C for subsequent determinations. As control, in a
separate set of experiments, hearts were maintained under
steady normoxia for 60 and 90 min after stabilization,
corresponding to the time points of 30 and 60 min
of postanoxic reoxygenation, respectively. Ventricles of
these untreated hearts were also dissected and stored at
-80C.
Kinase assay
Ventricular JNK activity was determined using a published
method [17] with minor modifications. Ventricles were
homogenized in ice-cold lysis buffer (in mmol/l: 20 Tris-
acetate (pH 7), 270 sucrose, 1 EGTA, 1 EDTA, 50 NaF, 10
b-glycerophosphate, 10 dithiothreitol (DTT), 10 4-nitro-
phenyl phosphate disodium salt hexahydrate (PNPP), 1%
Triton X-100 and inhibitors of proteases). Insoluble mate-
rial was removed by a 5 min centrifugation at 10,000g and
protein contents were measured by the method of Lowry
[18] with bovine serum albumin as standard.
Soluble ventricular protein extract (30 lg) were incubated
for 3 h at 4C in the presence of 1 lg GST-c-Jun(1–219)
bound to gluthatione-agarose beads as both JNK-specific
ligand and substrate. The beads were washed three times in
washing buffer (same as lysis buffer but with 0.1% Triton
X-100) and twice in kinase buffer (in mmol/l, 20 HEPES pH
7.5, 10 MgCl2, 20 b-glycerophosphate, 10 DTT, 10 PNPP
and inhibitors of proteases). Kinase reaction was carried out
for 30 min at 30C in 20 ll of kinase buffer containing 5 lCi
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[c-33P]ATP. Reaction products were resolved by 12%
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), gels
were dried, and phosphorylation signals were visualized by
autoradiography, quantified by PhosphoImager (Quantity-
one 1.4.0, Biorad) and expressed as fold increase relative to
the respective preanoxic value (stab).
Statistical analysis
All values are reported as mean ± standard error of the
mean (S.E.). The significance of any difference between
the groups was assessed using Student t-test. The statistical
significance was defined by a value of P \ 0.05.
Results
Profile of JNK activity during anoxia-reoxygenation
In control conditions (vehicle), JNK activity increased by
40% after 10–20 min anoxia (P \ 0.05). During reoxy-
genation, JNK activity progressively increased, peaking
after 30–40 min and further declined (Fig. 1). This cul-
mination of JNK activity was specifically related to
reoxygenation, since it was not attributable to the condi-
tions and the duration (135 min) of culture in the chamber
(Fig. 2).
Modulation of JNK activity by the opening state
of the mitoKATP channel
The mitoKATP channel opener diazoxide (50 lmol/l)
decreased JNK activity after 30 min anoxia and
throughout reoxygenation (Fig. 1). As the diazoxide-
induced inhibition was the strongest at the peak of JNK
activity (P \ 0.02), we selected this time point to phar-
macologically explore the possible mechanisms linking
the open state of the mitoKATP channel with the JNK
activity. Under preanoxic conditions, however, none of
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Fig. 1 Profile of JNK activity
in the embryonic ventricle
during anoxia-reoxygenation.
Activation of the mitoKATP
channel by diazoxide decreased
JNK activity. Upper panels
show representative
autoradiogram of JNK activity
during anoxia and
reoxygenation. Fold increase:
JNK activity is given relative to
the preanoxic stab value of
vehicle. Stab: 45 min preanoxic
stabilization; mean ± S.E. of
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Fig. 2 Stability of JNK activity under normoxia. In vitro culture
under steady normoxia did not affect ventricular JNK activity
assessed by kinase assay. Fold increase: JNK activity is given
relative to the mean of stab values. Stab: 45 min preanoxic
stabilization; stab + 60 min and stab + 90 min correspond to 30
and 60 min of reoxygenation in the anoxia-reoxygenation protocol,
respectively (see Fig. 1). Mean ± S.E.; n = 6–8 determinations of
JNK activity
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the reagents, alone or in combination, affected JNK
activity relative to vehicle (Fig. 3a) or disturbed the
regular contractile activity of the isolated hearts (not
shown). After 30–40 min reoxygenation, inhibition of
JNK activity by diazoxide was suppressed by the
mitoKATP channel blocker 5-HD (500 lmol/l) and,
importantly, 5-HD alone tripled JNK activity with respect
to vehicle (P \ 0.01) (Fig. 3b). The radical scavenger
MPG (1 mmol/l), known otherwise to abolish the diaz-
oxide-induced ROS production and cardioprotection at
reoxygenation [4], affected neither JNK activity nor the
diazoxide-induced JNK inhibition.
Modulation of JNK activity by sarcolemmal (LCC)
and mitochondrial (MCU) Ca2+ channels
Relative to vehicle, LCC inhibitor verapamil (10 nmol/l)
decreased JNK activity by 55%, whereas the mitochondrial
Ca2+ uniporter inhibitor Ru360 (10 lmol/l) had no signif-
icant effect (Fig. 3b). However, the 5-HD-mediated JNK
activity during reoxygenation was abolished by verapamil
and also by Ru360. These observations indicate that Ca2+
entry is a prerequisite for JNK stimulation and that MCU is
involved in JNK activation induced by the mitoKATP
channel blocker 5-HD.
Discussion
To the best of our knowledge, this is the first time that JNK
activity is explored in the embryonic myocardium sub-
mitted to an anoxic episode. Our main findings indicate
that JNK activity in the ventricle of the isolated embryonic
heart (1) is increased by anoxia and reoxygenation, (2) is
modulated by the open-state of the mitoKATP channel, and
(3) is dependent on Ca2+ flux through both LCC and MCU.
In the adult heart the effects of ischemia on JNK acti-
vation remain controversial whereas all studies show an
enhanced JNK activity during reperfusion [8, 9, 19, 20].
Our data indicate that JNK pathway contributes to the
short-term response of the heart to oxygen lack and rein-
troduction also during early embryogenesis, although the
metabolic consequences of anoxia-reoxygenation differ to
a certain extent from those of ischemia-reperfusion.
Although 5-HD has been shown to abolish ROS pro-
duction induced by the mitoKATP channel opener diazoxide
during reoxygenation [4], it markedly increased JNK
activity (Fig. 3b). Furthermore, the membrane permeable
antioxidant MPG which significantly reduces ROS pro-
duction at reoxygenation [4] did not suppress JNK
activation. Taken together, these observations clearly
indicate that endogenous ROS are not prerequisite for JNK
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Fig. 3 Pharmacological modulation of JNK activity in the embryonic
ventricle during preanoxic stabilization (a) and after 30–40 min
reoxygenation (b). JNK activity was dependent on the open-state of
the mitoKATP channel through Ca
2+-dependent mechanisms during
reoxygenation exclusively. In panel (a), JNK activity is given relative
to the value of vehicle. In panel (b), JNK activity is given relative to
the respective preanoxic stabilization value shown in panel (a). Insets
show representative autoradiograms of JNK activity during reoxy-
genation in relation to Ca2+ handling. DIAZ: diazoxide; verap:
verapamil; Ru: Ru360; Mean ± S.E. of number of determinations
indicated in columns; *P \ 0.05 vs. vehicle; #P \ 0.05 vs. DIAZ;
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activation in the embryonic myocardium by contrast with
neonatal cardiomyocytes [21] and adult heart [8]. Such a
developmental discrepancy implies that JNK pathway can
be modulated differently in prenatal and postnatal myo-
cardium since, for example, the physiological oxygen level,
the oxidative metabolism and the capacity to generate ROS
are lower in embryonic tissues [22–24]. The facts that
diazoxide improves recovery of atrio-ventricular conduc-
tion and E-C coupling during the first 20 min of
reoxygenation [4], and reduces JNK activity from the end
of anoxia onward (Fig. 1), suggest that this protection
might be indirectly related to a reduction of JNK activity.
It has been shown that after 30 min reoxygenation, that
is, when JNK activity reached its highest value (Fig. 1),
Ca2+ uptake is maximally increased in embryonic ven-
tricular cells [15] and contractility of the ventricle is
transiently above its basal level [25], reflecting a rise of
intracellular Ca2+. The present data support the concept
that extracellular Ca2+ entry through LCC is a prerequisite
for JNK activation in the reoxygenated embryonic myo-
cardium (Fig. 3b) alike in neonatal [21] and adult
cardiomyocytes [8].
Subcellular fractionation studies have shown that JNK
can also be localized within or associated with mitochon-
drial structures [26, 27]. The facts that mitochondria are
capable of taking up some of the cytosolic Ca2+ through the
MCU in case of Ca2+ overload [28, 29] and that mitoKATP
channel opening can decrease the mitochondrial inner
membrane potential (Wm) and Ca2+ content in the matrix
during hypoxia [30] could partly explain that MCU inhi-
bition suppressed the 5-HD-induced JNK activation. Our
results, indeed, show that blocking moderately Ca2+ entry
through sarcolemmal LCC or blocking Ca2+ flux into
mitochondrion through MCU reduces JNK activity during
reoxygenation, especially when mitoKATP channel are
closed by 5-HD.
Although Wm and mitochondrial Ca2+ concentration
have not been measured because of the thickness of the
tissue and interferences due to contractions, our findings
support the hypothesis that during reoxygenation Ca2+
entry through LCC and/or influx through MCU can activate
cytosolic JNK and/or JNK associated with mitochondria
(see model proposed in Fig. 4).
When mitoKATP channels are opened by diazoxide, Wm
is known to drop [30, 31], thereby limiting mitochondrial
Ca2+ entry through MCU and consequently Ca2+ overload,
reducing JNK activation. Conversely, when mitoKATP
channels are blocked by 5-HD, Wm should be maintained
and act as a driving force for Ca2+ transport through MCU,
which also could contribute to activate JNK.
Thus, in the embryonic heart, JNK activity exhibits a
characteristic pattern during anoxia and reoxygenation and
the respective open-state of LCC, MCU and mitoKATP
channels can be a major determinant of JNK activity in a
ROS-independent manner. This work provides a first step in
understanding the regulation of the JNK signaling pathway
in the fetal heart transiently exposed to hypoxia. In partic-
ular, the cellular targets as well as the long-term functional
consequences of an acute activation of this pathway during
cardiogenesis deserve further investigations.
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